Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.
Saved in:
| Title: | Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic. |
|---|---|
| Authors: | Kimura S; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan. mochinag@cc.saga-u.ac.jp., Katsuya H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Nakashima C; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Sueoka-Aragane N; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Hayashida K; Department of Medical Information, Saga University Hospital, Saga City, Saga, Japan., Sasaki K; Cancer Center, Saga University Hospital, Saga City, Saga, Japan., Sogawa R; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan., Furuno T; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan., Yamauchi M; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Sugiyama Y; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Noshiro H; Department of Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Esaki M; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Noguchi M; Department of Urology, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Takahashi H; Liver Center, Faculty of Medicine, Saga University Hospital, Saga University, Saga City, Saga, Japan., Anzai K; Division of Metabolism and Endocrinology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Yokoyama M; Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Sugita K; Division of Dermatology, Department Of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Yamashita Y; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Kawaguchi A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Shimanoe C; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan. |
| Source: | BMC immunology [BMC Immunol] 2025 Apr 16; Vol. 26 (1), pp. 33. Date of Electronic Publication: 2025 Apr 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172 (Electronic) Linking ISSN: 14712172 NLM ISO Abbreviation: BMC Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2172 |
|---|---|
| DOI: | 10.1186/s12865-025-00711-w |
